)
JEOL (6951) investor relations material
JEOL Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 FY2026 net sales were ¥24.5 billion, down 39.1% year-over-year, with an operating loss of ¥2.0 billion and a net loss attributable to owners of parent of ¥1,710 million, mainly due to timing of revenue recognition and tighter export controls.
Results were broadly in line with the initial plan, with business performance remaining on track despite declines.
Demand in Japan and Asia remained solid, while the US and Europe faced uncertainty from policy and economic conditions.
Comprehensive income was negative ¥204 million, a significant drop from ¥3,966 million in the previous year.
Financial highlights
Net sales: ¥24.5 billion (-39.1% YoY); Operating profit: -¥2.0 billion; Net profit: -¥1.7 billion; Gross profit: ¥11,768 million; Gross profit margin: 51.9% (up 0.4pt YoY).
Basic earnings per share fell to ¥(35.12) from ¥91.32 year-over-year.
FX impact (yen depreciation) and lower R&D costs partially offset declines from lower sales volume and higher SGA.
Overseas sales ratio was 68.0%.
Equity-to-asset ratio improved to 62.3% as of June 30, 2026.
Outlook and guidance
Full-year and first-half forecasts remain unchanged; full-year net sales forecast is ¥164,000 million, down 8.6% YoY.
Operating profit is projected at ¥26,500 million, up 1.9% YoY, with profit attributable to owners of parent expected at ¥21,300 million, down 3.6%.
Continued focus on semiconductors and life sciences as priority growth areas.
Medium-term plan targets net sales of ¥205.0 billion and operating profit of ¥44.0 billion by FY2029.
No revisions to previously announced earnings or dividend forecasts.
- Record net profit and share repurchase amid lower sales and business portfolio shift.6951
Q4 2026 - Revenue and profit fell, but financial stability and growth initiatives were maintained.6951
Q3 2026 - Vertical argon ion etching delivers uniform, high-resolution depth profiling with minimal roughness.6951
Status update - Sales and profits fell year-over-year, but Medical Equipment outperformed and dividends remain robust.6951
Q2 2026 - Strong quarterly growth in sales and profit, but full-year outlook signals a slight decline.6951
Q1 2026 - Strong sales growth and margin expansion drive upward revision to full-year outlook.6951
Q2 2025 - Revenue and profit surged in Q1 FY2025, led by robust equipment demand; outlook unchanged.6951
Q1 2025 - Record sales and profit, but lower net income and cautious outlook for next year.6951
Q4 2025 - Record profits and sales driven by robust equipment demand and margin gains.6951
Q3 2025
Next JEOL earnings date
Next JEOL earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)